Some reports have also demonstrated that embryonic fibroblasts lacking top2β were better protected against doxorubicin-induced cytotoxicity [54], and top2β deletion mice better prevented doxorubicin-induced cardiomyopathy [5]. The gene discussed is TOP2B; the disease is cardiomyopathy.